223 related articles for article (PubMed ID: 2478320)
21. A derivative of myelin-associated glycoprotein in cerebrospinal fluid of normal subjects and patients with neurological disease.
Yanagisawa K; Quarles RH; Johnson D; Brady RO; Whitaker JN
Ann Neurol; 1985 Oct; 18(4):464-9. PubMed ID: 2416268
[TBL] [Abstract][Full Text] [Related]
22. Myelin basic protein in cerebrospinal fluid as an indicator of active demyelination.
Cohen SR; Herndon RM; McKhann GM
Trans Am Neurol Assoc; 1976; 101():45-7. PubMed ID: 1028269
[No Abstract] [Full Text] [Related]
23. [Clinical usefulness of oligoclonal bands].
Falip M; Tintoré M; Jardí R; Duran I; Link H; Montalbán X
Rev Neurol; 2001 Jun 16-30; 32(12):1120-4. PubMed ID: 11562840
[TBL] [Abstract][Full Text] [Related]
24. Myelin basic protein in multiple sclerosis and other neurological disorders.
Kalistová H; Havrdová E; Uhrová J; Zeman D; Týblová M; Mrázová K
J Neurol; 2003 Jul; 250(7):874-5. PubMed ID: 12883934
[No Abstract] [Full Text] [Related]
25. Measurement of cerebrospinal fluid IgG in the diagnosis of multiple sclerosis.
Willoughby EW
Proc Aust Assoc Neurol; 1976; 13():127-33. PubMed ID: 829365
[TBL] [Abstract][Full Text] [Related]
26. [Myelin basic protein in the cerebrospinal fluid of patients with neurological disease: especially with malignant brain tumors].
Nakagawa H; Fujita T; Tsuruzono K; Kubo S; Yamada M; Miyawaki Y; Tokiyoshi K; Kanayama T; Hasegawa H; Koshino K
No Shinkei Geka; 1994 Feb; 22(2):111-8. PubMed ID: 7509461
[TBL] [Abstract][Full Text] [Related]
27. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
28. Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis.
Mastronardi FG; Mak B; Ackerley CA; Roots BI; Moscarello MA
J Clin Invest; 1996 Jan; 97(2):349-58. PubMed ID: 8567954
[TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: a test utilization study.
Greene DN; Schmidt RL; Wilson AR; Freedman MS; Grenache DG
Am J Clin Pathol; 2012 Aug; 138(2):262-72. PubMed ID: 22904139
[TBL] [Abstract][Full Text] [Related]
30. Intrathecal reactivity for myelin components precedes development of neurological symptoms in AIDS patients.
Silva AA; Câmara V; Quirico-Santos T
Arch Med Res; 1997; 28(3):391-6. PubMed ID: 9291637
[TBL] [Abstract][Full Text] [Related]
31. Oligoclonal immunoglobulins and immunoreactive myelin basic protein in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.
Cerri CG; Silani V; Scarlato G
Acta Neurol (Napoli); 1985; 7(3-4):311-4. PubMed ID: 2414977
[No Abstract] [Full Text] [Related]
32. Cross-reactive idiotypy in cerebrospinal fluid immunoglobulins in multiple sclerosis.
LaGanke CC; Freeman DW; Whitaker JN
Ann Neurol; 2000 Jan; 47(1):87-92. PubMed ID: 10632105
[TBL] [Abstract][Full Text] [Related]
33. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.
Beems T; Simons KS; Van Geel WJ; De Reus HP; Vos PE; Verbeek MM
Acta Neurochir (Wien); 2003 Jan; 145(1):37-43. PubMed ID: 12545260
[TBL] [Abstract][Full Text] [Related]
34. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
Link H; Huang YM
J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
[TBL] [Abstract][Full Text] [Related]
35. [Diagnosis and therapy of multiple sclerosis].
Woelk H; Neu I
Fortschr Med; 1980 Oct; 98(37):1427-30. PubMed ID: 6159291
[TBL] [Abstract][Full Text] [Related]
36. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders.
Whitaker JN; Lisak RP; Bashir RM; Krance R; Lawrence JA; Ch'ien LT; O'Sullivan P
Trans Am Neurol Assoc; 1978; 103():212-5. PubMed ID: 92844
[No Abstract] [Full Text] [Related]
37. Measurement of myelin basic protein by radioimmunoassay in closed head trauma, multiple sclerosis and other neurological diseases.
Mukherjee A; Vogt RF; Linthicum DS
Clin Biochem; 1985 Oct; 18(5):304-7. PubMed ID: 2414035
[TBL] [Abstract][Full Text] [Related]
38. [Neurofilament protein light in multiple sclerosis].
Zhang Y; Li X; Qiao J
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
[TBL] [Abstract][Full Text] [Related]
39. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
Valis M; Talab R; Stourac P; Andrys C; Masopust J
Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
[TBL] [Abstract][Full Text] [Related]
40. Biochemical markers of damage of the central nervous system in multiple sclerosis.
Bartosik-Psujek H; Stelmasiak Z
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():389-92. PubMed ID: 11977345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
